Calendar Radiopharm Theranostics Limited

Equities

RAD

AU0000181851

Market Closed - Australian S.E. 06:56:11 03/05/2024 BST 5-day change 1st Jan Change
0.04 AUD +11.11% Intraday chart for Radiopharm Theranostics Limited -13.04% -45.95%

Chart calendar Radiopharm Theranostics Limited

3935ed2ca018e1c1e93d1b3e.l6gGRLoev5eb6yhYfTYS8VB_XQUeIv2s8aCNUR4R25Y.3YVxN8pKjNbEgF8sL1FxnGA5MGFJF5T-m_rsZn0miaDjy3J3_lTGpM_bHA~7be956c5c0bfb26de838b69d704452f4

Upcoming events on Radiopharm Theranostics Limited

25/09/2024 Q4 2024 Earnings Release (Projected)
25/02/2025 Q2 2025 Earnings Release (Projected)
24/09/2025 Q4 2025 Earnings Release (Projected)
03/03/2026 Q2 2026 Earnings Release (Projected)

Past events on Radiopharm Theranostics Limited

14/04/2024 Extraordinary Shareholders Meeting
03/04/2024 15:40 MedInvest Biotech & Pharma Investor Conference
20/03/2024 22:00 NWR VirtualHealthcare Conference
11/03/2024 European Molecular Imaging Meeting
29/02/2024 B. Riley Securities Radiopharma Investor Conference
29/02/2024 03:42 Q2 2024 Earnings Release
30/01/2024 23:12 December 2023 Sales and Revenue Release - Activities Report
15/11/2023 23:00 Annual General Meeting
14/11/2023 Bell Potter Healthcare Conference
02/11/2023 The Capital Network's Emerging ASX Gems investment conference
30/10/2023 23:30 Business Update Call
30/10/2023 23:27 September 2023 Sales and Revenue Release - Activities Report
31/08/2023 02:38 Q4 2023 Earnings Release
17/08/2023 Extraordinary Shareholders Meeting
31/07/2023 00:40 June 2023 Sales and Revenue Release - Activities Report
14/06/2023 02:00 Business Update Call
27/04/2023 06:05 March 2023 Sales and Revenue Release - Activities Report
02/04/2023 Jefferies Radiopharma Innovation Summit
23/03/2023 Wholesale Investor Emergence Conference
20/03/2023 22:00 NWR Virtual Healthcare Conference

Annual results

Fiscal PeriodJuni 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,19
0,29
-34.91%

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00


-12,4
-12,3
-0.66%
-20,2
-15,0
-34.3%

-28,3

EBIT
Million USD
Released
Forecast
Spread
0,00


-14,4
-16,3
11.41%
-22,3
-17,2
-29.58%

-29,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-20,9
-22,2
6.08%
-22,4
-17,5
-27.8%

-29,0

Net income
Million USD
Released
Forecast
Spread
-0,35


-20,9
-22,2
5.98%
-22,4
-17,5
-27.85%

-29,0

EPS
USD
Released
Forecast
Spread
0,00


-0,12
-0,08
-37.18%
-0,07
-0,06
-25.86%

-0,07

Announcement Date23/11/2130/08/2231/08/23-

Quarterly results

Fiscal PeriodJune 2023 Q1 2023 Q2 2023 S1 2023 S2 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales
Million USD
Released
Forecast
Spread
0,10
0,00
-
0,09
0,00
-
0,20


0,00
0,19
-

0,00

0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread









-14,6
-8,54
-70.41%





















Net income
Million USD
Released
Forecast
Spread






-8,48


-14,3
-8,54
-67.26%





















EPS
USD
Released
Forecast
Spread






-0,03


























Announcement Date28/11/2228/02/2328/02/2331/08/23-29/02/24-----

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RAD Stock
  4. Calendar Radiopharm Theranostics Limited